These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9412713)

  • 1. Antiretroviral therapy and HIV-related retinal microangiopathy.
    Pivetti-Pezzi P; Accorinti M; Ciapparoni V; Vullo V; Aiuti F
    AIDS; 1997 Dec; 11(15):1890-1. PubMed ID: 9412713
    [No Abstract]   [Full Text] [Related]  

  • 2. Focusing on the second phase of plasma HIV-1 RNA clearance.
    Lafeuillade A; Poggi C; Sayada C; Pellegrino P; Profizi N
    AIDS; 1997 Feb; 11(2):264-6. PubMed ID: 9030385
    [No Abstract]   [Full Text] [Related]  

  • 3. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
    Spooner KM; Lane HC; Masur H
    Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
    [No Abstract]   [Full Text] [Related]  

  • 4. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observing in HIV infections].
    Vittecocq D
    Presse Med; 1998 Nov; 27(35):1818-9. PubMed ID: 9850703
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of drug resistance in patients receiving combinations of zidovudine, didanosine and nevirapine.
    Conway B; Wainberg MA; Hall D; Harris M; Reiss P; Cooper D; Vella S; Curry R; Robinson P; Lange JM; Montaner JS
    AIDS; 2001 Jul; 15(10):1269-74. PubMed ID: 11426071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolution of Mycobacterium avium complex bacteremia following highly active antiretroviral therapy.
    Hadad DJ; Lewi DS; Pignatari AC; Martins MC; Vitti Júnior W; Arbeit RD
    Clin Infect Dis; 1998 Mar; 26(3):758-9. PubMed ID: 9524856
    [No Abstract]   [Full Text] [Related]  

  • 8. Zidovudine therapy and HIV type 1 mutations in children with symptomatic HIV type 1 infection: effect of switching to didanosine or zidovudine plus didanosine therapy. Italian Multicenter Study Group on HIV Mutations in Children.
    Principi N; Marchisio P; Esposito S; Rossi P; Gattinara GC; Galli L; Gabiano C; Zuccotti GV; Orlandi P
    AIDS Res Hum Retroviruses; 1998 Dec; 14(18):1653-9. PubMed ID: 9870319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing patterns of drug-taking behavior with a multiple drug regimen in an AIDS clinical trial.
    Kastrissios H; Suárez JR; Katzenstein D; Girard P; Sheiner LB; Blaschke TF
    AIDS; 1998 Dec; 12(17):2295-303. PubMed ID: 9863872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of zidovudine and multidrug-resistance mutations in the HIV-1 reverse transcriptase gene in therapy-naive patients receiving stavudine plus didanosine combination therapy. STADI Group.
    Pellegrin I; Izopet J; Reynes J; Denayrolles M; Montes B; Pellegrin JL; Massip P; Puel J; Fleury H; Segondy M
    AIDS; 1999 Sep; 13(13):1705-9. PubMed ID: 10509572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial.
    Lancet; 1997 May; 349(9063):1413-21. PubMed ID: 9164314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-retroviral treatment. Treatment modification: toxicity management].
    Ocaña I; Laguna F; Pulido F; Bascuñana A
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():31-5. PubMed ID: 9053025
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mollusca contagiosa in HIV-infected children receiving optimal antiretroviral therapy].
    Horneff G; Wahn V
    Klin Padiatr; 2000; 212(2):83-4. PubMed ID: 10812559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired absorption of rifabutin by concomitant administration of didanosine.
    Marzolini C; Chave JP; Telenti A; Brenas-Chinchon L; Biollaz J
    AIDS; 2001 Nov; 15(16):2203-4. PubMed ID: 11684946
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for HIV infection.
    Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of toxoplasma encephalitis in AIDS patients treated with Didanosine hospitalised in a French infectious service.
    Sarciron ME; Ghérardi A; Delorme C; Peyramond D; Pétavy AF
    Curr HIV Res; 2004 Oct; 2(4):301-7. PubMed ID: 15544451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Researchers report sustained suppression of HIV with nevirapine--didanosine--zidovudine.
    Am J Health Syst Pharm; 1998 Jun; 55(11):1106, 1108. PubMed ID: 9626369
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observational study on the efficacy of the application of two classical regimens of triple antiretroviral therapy].
    Eiros Bouza JM; Ortega Lafont M; Ortiz de Lejarazu R; Bachiller Luque P; de Luis Román DA
    An Med Interna; 2003 May; 20(5):239-42. PubMed ID: 12831297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated cycles of alternate administration of fludarabine and Zidovudine plus Didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels.
    Fraternale A; Casabianca A; Orlandi C; Chiarantini L; Brandi G; Silvestri G; Magnani M
    Virology; 2002 Oct; 302(2):354-62. PubMed ID: 12441079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.